Breaking News Instant updates and real-time market news.

MCO

Moody's

$144.24

0.31 (0.22%)

, GS

Goldman Sachs

$238.53

-1.27 (-0.53%)

04:55
10/14/17
10/14
04:55
10/14/17
04:55

Institute of International Finance to hold a meeting

2017 IIF Annual Membership Meeting is being held in Washington, D.C. on October 11-14.

MCO

Moody's

$144.24

0.31 (0.22%)

GS

Goldman Sachs

$238.53

-1.27 (-0.53%)

DB

Deutsche Bank

$16.58

-0.12 (-0.72%)

UBS

UBS

$17.28

0.1 (0.58%)

PYPL

PayPal

$68.66

-0.2 (-0.29%)

V

Visa

$108.66

0.55 (0.51%)

RY

Royal Bank of Canada

$79.30

0.21 (0.27%)

JPM

JPMorgan

$95.86

-0.13 (-0.14%)

SAN

Banco Santander

$6.58

-0.06 (-0.90%)

RBS

RBS

$7.38

0.07 (0.96%)

BNS

Bank of Nova Scotia

$64.60

0.2 (0.31%)

ITUB

Itau Unibanco

$14.13

0.09 (0.64%)

BLK

BlackRock

$475.49

-5.1 (-1.06%)

MS

Morgan Stanley

$48.30

-0.29 (-0.60%)

AIG

AIG

$63.16

0.61 (0.98%)

BBVA

Banco Bilbao

$8.68

-0.01 (-0.12%)

MET

MetLife

$52.72

-0.01 (-0.02%)

C

Citi

$72.11

-0.26 (-0.36%)

CS

Credit Suisse

$15.83

0.11 (0.70%)

SPGI

S&P Global

$161.82

0.7 (0.43%)

BCS

Barclays

CG

Carlyle Group

$24.05

0.1 (0.42%)

BAC

Bank of America

$25.83

0.38 (1.49%)

TRI

Thomson Reuters

$46.81

0.38 (0.82%)

BK

BNY Mellon

$54.67

-0.07 (-0.13%)

AB

AllianceBernstein

$25.00

-0.2 (-0.79%)

  • 14

    Oct

  • 15

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 03

    Nov

  • 05

    Nov

  • 07

    Nov

  • 29

    Nov

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

MCO Moody's
$144.24

0.31 (0.22%)

08/30/17
FBCO
08/30/17
NO CHANGE
Target $137
FBCO
Neutral
Moody's price target raised to $137 from $131 at Credit Suisse
Credit Suisse analyst Anjaneya Singh raised his price target for Moody's to $137 from $131 on valuation following its acquisition of Bureau van Dijk, which closed on August 10th. The analyst reiterates a Neutral rating on the shares.
05/11/17
EVER
05/11/17
NO CHANGE
EVER
Moody's Tactial Outperform rating removed at Evercore ISI
Evercore ISI analyst Warren Gardiner removed Moody's as a Tactical Outperform and reverted back to an In Line rating. The analyst said Moody's reported an exceptional Q1, but the catalyst has passed and expects shares to trade around his $117 price target.
02/21/17
MSCO
02/21/17
DOWNGRADE
Target $114
MSCO
Equal Weight
Moody's downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Toni Kaplan downgraded Moody's to Equal Weight and raised its price target to $114 from $112. Kaplan believes valuation reflects strong issuance expectations for 2017 and does not fully discount difficult 2H comps and potential headwinds from the elimination of interest deductibility and other regulatory changes.
01/10/17
01/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Moody's (MCO) was downgraded to Equal Weight from Overweight at Barclays and to Neutral from Buy at UBS. 2. Goldman Sachs (GS) and Comerica (CMA) were downgraded to Sell from Neutral at Citi. 3. T-Mobile (TMUS) downgraded to Neutral from Buy at MoffettNathanson. 4. AMAG Pharmaceuticals (AMAG) downgraded to Market Perform from Outperform at Leerink and to Neutral from Buy at Janney Capital. 5. BP (BP) downgraded to Market Perform from Outperform at BMO Capital analyst Brendan Warn citing his belief that the company will make a major acquisition this year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GS Goldman Sachs
$238.53

-1.27 (-0.53%)

10/09/17
FBCO
10/09/17
DOWNGRADE
FBCO
Neutral
Goldman Sachs downgraded to Neutral from Outperform at Credit Suisse
09/12/17
KBWI
09/12/17
NO CHANGE
KBWI
Market Perform
Keefe Bruyette 'somewhat skeptical' of Goldman Sachs revenue targets
Keefe Bruyette analyst Brian Kleinhanzl noted that Goldman Sachs co-COO Harvey Schwartz identified $5B in revenue opportunities that the company sees over the next 3 years, though he is "somewhat skeptical" of the bank's ability to hit these targets given that its strategy requires penetrating new markets or segments outside of its traditional strengths. The analyst, who thinks Goldman remains a "show-me stock," keeps a Market Perform rating on the shares.
09/26/17
DBAB
09/26/17
DOWNGRADE
Target $136
DBAB
Hold
PNC Financial downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Matt O'Connor downgraded PNC Financial (PNC) to Hold as he seeks to lessen exposure to traditional banks. The analyst sees net interest income growth slowing and credit costs inching up as the Fed raises short rates and the yield curve flattens. He believes a number of positives are priced into PNC shares. O'Connor upped his price target for the stock to $136 from $130. The analyst continues to prefer banks with a "turnaround angle," like Goldman Sachs (GS) and Wells Fargo (WFC), and remains positive on capital markets businesses like Morgan Stanley (MS). O'Connor this morning also downgraded JPMorgan (JPM) to Hold.
10/09/17
10/09/17
DOWNGRADE
Target $255

Neutral
Goldman Sachs downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Susan Roth Katzke downgraded Goldman Sachs to Neutral from Outperform given the recovery in the shares and the now more limited total return to her target price, which she raised to $255 from $240.
DB Deutsche Bank
$16.58

-0.12 (-0.72%)

08/31/17
KBWI
08/31/17
DOWNGRADE
KBWI
Market Perform
Deutsche Bank downgraded to Market Perform at Keefe Bruyette (pre-open)
Pre-open, Keefe Bruyette analyst George Karamonos downgraded Deutsche Bank to Market Perform from Outperform.
09/21/17
HSBC
09/21/17
UPGRADE
HSBC
Hold
Deutsche Bank upgraded to Hold from Reduce at HSBC
HSBC analyst Alevizos Alevizakos upgraded Deutsche Bank to Hold citing valuation with the shares down 15% since the Q2 report. The analyst has an EUR 14 price target for the shares and believes the bank's outlook "remains uncertain."
09/21/17
09/21/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Intuit (INTU) upgraded to Outperform from Market Perform at Wells Fargo with analyst Siti Panigrahi saying share gains in the consumer tax business and QuickBooks expansion into self-employed and international markets should drive double-digit revenue and earnings growth over the coming years. 2. Deutsche Bank (DB) upgraded to Hold from Reduce at HSBC wityh analyst Alevizos Alevizakos citing valuation with the shares down 15% since the second quarter report. 3. Sealed Air (SEE) upgraded to Buy from Neutral at BofA/Merrill with analyst George Staphos saying the share drop combined with growth outlook provide an opportunity. 4. PSEG (PEG) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Devin McDermott saying he sees its risk-reward profile as "skewed heavily to the upside" given the stock's underperformance year-to-date versus peers and the several constructive regulatory initiatives that are pending. 5. FactSet (FDS) upgraded to Buy from Neutral at Northcoast. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/15/17
MACQ
08/15/17
DOWNGRADE
MACQ
Underperform
Deutsche Bank downgraded to Underperform from Neutral at Macquarie
Macquarie analyst Piers Brown downgraded Deutsche Bank to Underperform citing further market share loses in trading and FICC share erosion.
UBS UBS
$17.28

0.1 (0.58%)

08/11/17
WEDB
08/11/17
DOWNGRADE
WEDB
Neutral
Luxoft downgraded on weakness of multiple clients at Wedbush
As noted earlier, Wedbush downgraded Luxoft (LXFT) to Neutral from Outperform. As reasons for the downgrade, analyst Moshe Katri cited the deceleration in the spending of its top two clients, Deutsche Bank (DB) and UBS (UBS), and a "spending pause" by a number of its other clients which are undergoing M&A. Target to $50 from $67.
02/07/17
02/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Buy from Neutral at Citi with analyst Robyn Karnauskas saying the Alzheimer's Phase 2 data already reported and no Phase 3 results until 2019/20, upside in the stock rests on the stability of Biogen's multiple sclerosis business and success of the Spinraza launch in spinal muscular atrophy. 2. Caterpillar (CAT) upgraded to Overweight from Equal Weight at Barclays with analyst Robert Wertheimer saying investors likely will never get a chance to buy the company's revenue with as much upside as in 2017. 3. Sysco (SYY) upgraded to Overweight from Neutral at JPMorgan with analyst John Ivankoe saying the shares should be bought in the low $50s. He raised his price target for the shares to $57 from $55. 4. Nokia (NOK) upgraded to Overweight from Equal Weight at Morgan Stanley. 5. UBS (UBS) upgraded to Neutral from Underperform at BofA/Merrill with analyst Andrew Stimpson saying negative catalysts have played out. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/26/17
JPMS
06/26/17
UPGRADE
JPMS
Overweight
UBS upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Kian Abouhossein upgraded UBS to Overweight with an increased price target of CHF 19. The analyst views the current valuation as attractive.
06/26/17
06/26/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Coach (COH) upgraded to Buy from Neutral by Buckingham analyst Scott Krasik, who sees further upside based on expectations core margins can expand, Kate Spade accretion will exceed expectations, and thinks the company will make further additive acquisitions over the next few years. 2. Costco (COST) upgraded to Outperform from Market Perform by Raymond James analyst Budd Bugatch, who noted that the shares have pulled back approximately 13% since June 15 in reaction to Amazon's (AMZN) purchase of Whole Foods (WFM), which he views as providing a buying opportunity. 3. Pandora (P) upgraded to Sector Weight from Underweight at Pacific Crest by analyst Andy Hargreaves, who said the SiriusXM-appointed board members are likely to push for a moderated cash burn rate. The analyst believes lower cash burn, even at the expense of subscriber growth, would be a positive for Pandora. 4. UBS (UBS) upgraded to Overweight from Neutral by JPMorgan analyst Kian Abouhossein, who views the current valuation as attractive. 5. Goldman analyst Michael Lapides upgraded Duke Energy (DUK) to Buy and raised its price target to $85 from $82 saying relative valuation is compelling. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PYPL PayPal
$68.66

-0.2 (-0.29%)

10/11/17
MSCO
10/11/17
UPGRADE
MSCO
Overweight
PayPal upgraded to Overweight from Equal Weight at Morgan Stanley
10/13/17
JEFF
10/13/17
NO CHANGE
Target $80
JEFF
Buy
PayPal price target raised to $80 from $70 at Jefferies
Jefferies analyst Ramsey El-Assal raised his price target for PayPal to $80 saying he sees "potentially material upside" to forward estimates given "continued dramatic growth" in the Venmo user base. In fiscal year 2020, if 20% of users pay with Venmo a few times per month, the incremental earnings contribution could be 5%-10%, El-Assal tells investors in a research note. The analyst notes that intra-quarter data points imply modest upside to Q3 consensus estimates. He believes, though, that elevated expectations will likely limit the share upside on the results. The analyst keeps a Buy rating on PayPal.
10/11/17
10/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Buy from Hold at Jefferies with analyst Jeffrey Holford saying J&J's Pharma division is "under-modeled" by analysts and will drive above-consensus revenue and earnings growth. 2. Visa (V) and MasterCard (MA) were upgraded to Outperform from Market Perform at Wells Fargo. 3. Colgate-Palmolive (CL) upgraded to Buy from Hold at SunTrust with analyst William Chappell saying the recent three consecutive quarters of weak results is an "anomaly" given the company's long term track record of consistent mid-single-digit or higher organic growth. 4. AbbVie (ABBV) upgraded to Outperform from Market Perform at Cowen with analyst Steve Scala saying AbbVie "showed the best" of all the companies at Cowen's Annual Therapeutics Conference last week. 5. PayPal (PYPL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst James Faucette calling it among the few large companies that can deliver high-teens revenue and 20% EPS growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/17
10/11/17
UPGRADE
Target $76

Overweight
PayPal upgraded to Overweight on revised view of eBay risk at Morgan Stanley
As previously reported, Morgan Stanley analyst James Faucette upgraded PayPal (PYPL) to Overweight from Equal Weight, calling it among the few large companies that can deliver high-teens revenue and 20% EPS growth. While he previously was on the sidelines due to risk from its contract renegotiation with eBay (EBAY), he now believes the market may be overly concerned with it as he thinks the most likely renewal structure will feature rebates from PayPal to eBay, he tells investors. Faucette raised his price target on PayPal shares to $76 from $62. He also raised his price target on eBay to $33 from $29, though he keeps an Underweight rating on its shares.
V Visa
$108.66

0.55 (0.51%)

10/11/17
WELS
10/11/17
UPGRADE
Target $160
WELS
Outperform
MasterCard upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Donald Fandetti took over coverage of MasterCard (MA) with an Outperform rating and $160 price target, up from the firm's prior rating of Market Perform and $130 price target. Fandetti, who believes MasterCard is well positioned to deliver roughly 20% EPS growth, has a near-term preference for Visa (V), citing valuation and Visa Europe.
10/13/17
SPHN
10/13/17
INITIATION
Target $125
SPHN
Overweight
Visa initiated with an Overweight at Stephens
Stephens analyst Brett Huff started Visa (V) with an Overweight rating and $125 target, saying he thinks the company and peer MasterCard (MA) can beat near- and medium-term consensus expectations and can support higher multiples. While he also started MasterCard with an Overweight rating, he likes Visa "a bit better," partially since he sees Visa Europe as a meaningful revenue and profit growth driver, Huff tells investors.
10/13/17
10/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Visa (V) and MasterCard (MA) were initiated with an Overweight at Stephens. 2. Acuity Brands (AYI) initiated with a Sector Weight at KeyBanc. 3. Williams-Sonoma (WSM) and RH (RH) were initiated with a Hold at Stifel. 4. Signature Bank (SBNY) assumed with a Neutral at Piper Jaffray. 5. NewLink Genetics (NLNK) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
RY Royal Bank of Canada
$79.30

0.21 (0.27%)

04/03/17
TDSI
04/03/17
DOWNGRADE
TDSI
Hold
Royal Bank of Canada downgraded to Hold from Buy at TD Securities
TD Securities analyst Mario Mendonca downgraded Royal Bank of Canada to Hold primarily due to valuation and relative outperformance.
08/21/17
HOWW
08/21/17
DOWNGRADE
HOWW
Sector Perform
Royal Bank of Canada downgraded to Sector Perform at Scotia Howard Weil
12/01/16
RAFF
12/01/16
DOWNGRADE
RAFF
Hold
Royal Bank of Canada downgraded to Hold from Buy at Rafferty Capital
02/27/17
KBWI
02/27/17
UPGRADE
KBWI
Market Perform
Royal Bank of Canada upgraded to Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Klock upgraded Royal Bank of Canada to Market Perform from Underperform with an increased price target of C$99.
JPM JPMorgan
$95.86

-0.13 (-0.14%)

10/09/17
FBCO
10/09/17
NO CHANGE
Target $110
FBCO
Outperform
JPMorgan price target raised to $110 from $103 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke raised her price target for JPMorgan to $110 from $103 on valuation. The analyst reiterates an Outperform rating on the shares.
09/26/17
DBAB
09/26/17
DOWNGRADE
Target $96
DBAB
Hold
JPMorgan downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Matt O'Connor downgraded JPMorgan to Hold as he seeks to lessen exposure to traditional banks. The analyst sees net interest income growth slowing and credit costs inching up as the Fed raises short rates and the yield curve flattens. He believes further meaningful outperformance of JPMorgan shares will be harder amid increased competition within investment banking and trading as well as slowing loan growth. The analyst raised his price target for the shares to $96 from $90. The bank closed yesterday down 71c to $94.12.
09/26/17
09/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JPMorgan (JPM) and PNC Financial (PNC) were downgraded to Hold from Buy at Deutsche Bank. 2. Aflac (AFL) downgraded to Sell from Neutral at Citi with analyst Suneet Kamath saying the company is at an inflection point as Aflac Japan is too large to show meaningful growth and Aflac U.S. is "too small to move the growth needle." 3. Cardtronics (CATM) downgraded to Market Perform from Outperform at William Blair with analyst Robert Napoli citing the changes in the Australian market. 4. Cheesecake Factory (CAKE), Shake Shack (SHAK), and Habit Restaurants (HABT) were downgraded to Neutral from Outperform at Wedbush. 5. Genocea (GNCA) downgraded to Hold from Buy at Stifel with analyst Stephen Willey saying his visibility and confidence "remains admittedly low" after the company shelved GEN-003 and said it will shift focus on immuno-oncology and the development of neoantigen cancer vaccines. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SAN Banco Santander
$6.58

-0.06 (-0.90%)

09/07/17
MSCO
09/07/17
UPGRADE
MSCO
Overweight
Banco Santander upgraded to Overweight from Equal Weight at Morgan Stanley
08/25/17
JANY
08/25/17
NO CHANGE
JANY
Neutral
Janney says end to Fed action an incremental positive for Santander Consumer
Janney Capital analyst John Rowan said the Federal Reserve terminating an enforcement action against Santander Holdings USA is clearly an incremental positive for Santander Consumer, but he doesn't think it changes the fundamentals of its business or the outlook for capital actions. He also does not think the termination changes the parent company's rumored interest or ability to acquire a larger stake in Santander Consumer, he tells investors. Rowan keeps a Neutral rating on Santander Consumer shares.
08/15/17
08/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deere (DE) downgraded to Neutral from Buy at BofA/Merrill with analyst Ross Gilardi saying he is cautious into the print given recent data and expects the pace of earnings performance relative to expectations to begin to subside. 2. Zynerba (ZYNE) was downgraded to Perform from Outperform at Oppenheimer and to Hold from Buy at Jefferies. 3. Uniti Group (UNIT) downgraded to Neutral from Buy at BofA/Merrill with analyst David Barden saying Windstream's (WIN) dividend cut increases concerns about the health of the business and, combined with Uniti's increasing cost of capital, creates a negative feedback loop for the stock. 4. Farmland Partners (FPI) downgraded to Neutral from Outperform at Baird with the firm's analyst saying financial leverage is moving towards 18x EBITDA following the recent preferred offering, and the participating rights could create a liability for the common holders that could grow over time and a common dividend AFFO payout ratio over 130% estimated through YE19. 5. Banco Santander (SAN) downgraded to Neutral from Buy at Goldman Sachs with analyst Jose Abad seeing the valuation as full following the recent outperformance of the shares. The analyst lowered his price target for the shares to EUR 6.40. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/15/17
GSCO
08/15/17
DOWNGRADE
GSCO
Neutral
Banco Santander downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Jose Abad downgraded Banco Santander to Neutral saying he valuation as full following the recent outperformance of the shares. The analyst lowered his price target for the shares to EUR 6.40.
RBS RBS
$7.38

0.07 (0.96%)

10/10/17
10/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Prudential (PRU) upgraded to Buy from Neutral at FBR Capital. 2. RBS (RBS) was upgraded to Neutral from Sell at Citi and to Neutral from Underperform at Credit Suisse. 3. Palo Alto Networks (PANW) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Keith Weiss saying he sees building traction across the company's portfolio of solutions and he views it as one of the best positioned vendors to execute on an integrated security platform story. 4. Illinois Tool Works (ITW) upgraded to Neutral from Underweight at JPMorgan with analyst Ann Duignan saying organic growth is likely to be better than forecast in the third quarter. 5. McKesson (MCK) upgraded to Outperform from Market Perform at Cowen with analyst Charles Rhyee saying the transition towards differential specialty pricing will drive both earnings growth and multiple expansion. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/10/17
10/10/17
UPGRADE

Neutral
RBS upgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Claire Kane upgraded RBS to Neutral from Underperform and raised her price target on the shares to 275p from 255p. The analyst welcomes positive developments on the capital side, notably on IFRS 9, and short-term momentum in the business looks strong.
10/10/17
SBSH
10/10/17
UPGRADE
SBSH
Neutral
RBS upgraded to Neutral from Sell at Citi
Citi analyst Andrew Coombs upgraded Royal Bank of Scotland to Neutral with a 275p price target saying the bank is "most geared" to rising rates and has a "defensive asset mix."
10/10/17
FBCO
10/10/17
UPGRADE
FBCO
Neutral
RBS upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse analyst Claire Kane upgraded Royal Bank of Scotland to Neutral with a 275p price target.
BNS Bank of Nova Scotia
$64.60

0.2 (0.31%)

05/23/17
LEHM
05/23/17
UPGRADE
LEHM
Overweight
Bank of Nova Scotia upgraded to Overweight from Equal Weight at Barclays
Barclays analyst John Aiken upgraded Bank of Nova Scotia to Overweight saying he's more constructive on the outlook for earnings growth for the Canadian banks in 2018. The analyst raised his price target for the shares to C$84 from C$78.
03/07/17
CIBC
03/07/17
UPGRADE
CIBC
Outperformer
Bank of Nova Scotia upgraded to Outperformer from Neutral at CIBC
03/01/17
TDSI
03/01/17
DOWNGRADE
TDSI
Buy
Bank of Nova Scotia downgraded to Buy from Action List Buy at TD Securities
TD Securities analyst Mario Mendonca downgraded Bank of Nova Scotia to Buy to reflect increased concerns around Latin America commercial loan growth.
09/20/17
SBSH
09/20/17
UPGRADE
SBSH
Buy
Bank of Nova Scotia upgraded to Buy from Neutral at Citi
ITUB Itau Unibanco
$14.13

0.09 (0.64%)

04/11/17
SCOT
04/11/17
UPGRADE
SCOT
Sector Perform
Itau Unibanco upgraded to Sector Perform from Underperform at Scotiabank
11/30/16
SBSH
11/30/16
INITIATION
SBSH
Buy
Itau Unibanco coverage assumed with a Buy at Citi
08/25/17
SBSH
08/25/17
DOWNGRADE
SBSH
Neutral
Itau Unibanco downgraded to Neutral from Buy at Citi
Citi analyst Jorg Friedemann downgraded Itau Unibanco to Neutral from Buy citing the stock's outperformance since May. Macro uncertainties affecting operating trends give him caution after the outperformance, he tells investors.
07/12/17
JPMS
07/12/17
DOWNGRADE
Target $12.5
JPMS
Neutral
Itau Unibanco downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Domingos Falavina downgraded Itau Unibanco to Neutral citing concerns over net investment income growth in the second half of 2017 and 2018. The analyst expects spreads on loans will decrease. He has a $12.50 price target for the shares.
BLK BlackRock
$475.49

-5.1 (-1.06%)

10/12/17
FBCO
10/12/17
NO CHANGE
Target $612
FBCO
Outperform
BlackRock price target raised to $612 from $597 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler raised his price target for BlackRock to $612 from $597 following Q3 results. The analyst reiterates an Outperform rating on the shares.
10/12/17
LEHM
10/12/17
NO CHANGE
Target $520
LEHM
Overweight
BlackRock price target raised to $520 from $500 at Barclays
Barclays analyst Jeremy Campbell raised his price target for BlackRock to $520 saying the company yesterday reported solid fundamental results for Q3. He believes BlackRock is well positioned to continue to garner inflows and grow assets under management at a higher pace than the other asset managers. The analyst keeps an Overweight rating on the shares.
09/28/17
09/28/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Buy from Neutral at Longbow with analyst Alton Stump citing better than expected third quarter U.S. comparable store sales trends. 2. Philip Morris (PM) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Judy Hong saying the company offers a "rare innovation product cycle story within Staples" along with the strongest global positioning in next generation products. 3. BlackRock (BLK) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alexander Blostein saying he expects an acceleration in annual operating income growth given improving trends in active, easing pressures on blended fee rates, and scaling of its tech platform which should lead to sustainable multiple improvement. 4. Potbelly (PBPB) upgraded to Overweight from Neutral at Piper Jaffray with analyst Nicole Miller Regan saying she believes a "compelling" turnaround is building. 5. Huntsman (HUN) upgraded to Outperform from Market Perform at Wells Fargo with analyst Frank Mitsch saying the recent weakness in the shares is a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/12/17
WELS
10/12/17
NO CHANGE
Target $475
WELS
Market Perform
BlackRock price target raised to $475 from $450 at Wells Fargo
Wells Fargo raised its price target for BlackRock to $475 from $450 following quarterly results, while reiterating a Market Perform rating on the shares.
MS Morgan Stanley
$48.30

-0.29 (-0.60%)

10/09/17
10/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Outperform from Market Perform at Wells Fargo with analyst Larry Biegelsen saying J&J is poised to reaccelerate its sales growth due to accretion from the Actelion acquisition, a "more measured" than expected impact from biosimilar competition, "solid performance" of key drugs and a pipeline that is "coming to fruition." 2. Morgan Stanley (MS) upgraded to Outperform from Neutral at Credit Suisse with analyst Susan Roth Katzke citing the over 10% total return potential in the shares. 3. Disney (DIS) upgraded to Top Pick from Outperform at RBC Capital with analyst Steven Cahall saying he thinks the company has reached a turning point with ESPN approaching less than 20% of earnings and "non-Media" Disney remaining a global leader in content that is executing well. 4. INC Research (INCR) upgraded to Buy from Hold at Jefferies analyst David Windley saying the recent share pullback provides a "compelling" entry point. 5. British American Tobacco (BTI) upgraded to Buy from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/09/17
FBCO
10/09/17
UPGRADE
Target $54
FBCO
Outperform
Morgan Stanley upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Susan Roth Katzke upgraded Morgan Stanley to Outperform from Neutral given the over 10% total return potential in the shares. The analyst also raised her price target on the shares to $54 from $49.
10/09/17
FBCO
10/09/17
UPGRADE
FBCO
Outperform
Morgan Stanley upgraded to Outperform from Neutral at Credit Suisse
AIG AIG
$63.16

0.61 (0.98%)

09/11/17
LEHM
09/11/17
NO CHANGE
LEHM
Irma and Harvey insured losses expected to top $100B, says Barclays
Barclays analyst Jay Gelb notes initial indications are Hurricane Irma's impact on Florida could result in insured losses of up to $60B. Irma will likely be the largest storm to ever impact the U.S., although not as bad as if Miami suffered a direct hit, Gelb tells investors in a research note on the insurance space titled "Devastating Irma Impact on Insurers, But It Could Have Been Worse." All in, Irma and Harvey insured losses are expected to exceed $100B, Gelb points out. He believes the re/insurance stocks could suffer from near-term uncertainty regarding the extent of losses. Of the names he covers, the analyst expects Everest Re (RE), XL Group (XL), RenaissanceRe (RNR), Validus (VR) and Aspen Insurance (AHL) "to take the brunt of Irma losses." Book value declines of more than 20% could require equity capital raises, Gelb contends. He says Chubb (CB), Travelers (TRV) and Hartford Financial (HIG) have relatively less exposure while AIG (AIG) could have greater losses among the primary insurers.
10/10/17
MSCO
10/10/17
NO CHANGE
MSCO
Overweight
AIG Q3 catastrophe losses 'manageable,' says Morgan Stanley
Morgan Stanley analyst Kai Pan said AIG's preliminary Q3 catastrophe loss estimate of $2.9B-$3.1B is roughly in-line with expectations and he views them as "manageable," given they represent only about a 2.6% impact to book value. The analyst, who thinks the news may alleviate capital concerns for AIG, reiterates his Overweight rating on the shares.
09/11/17
BUCK
09/11/17
INITIATION
Target $52
BUCK
Underperform
AIG initiated with an Underperform at Buckingham
Buckingham analyst Amit Kumar initiated AIG with an Underperform and a $52 price target.
09/01/17
MSCO
09/01/17
NO CHANGE
MSCO
Harvey loss uncertainty to remain overhang on P&C stocks, says Morgan Stanley
Morgan Stanley analyst Kai Pan currently estimates $15B-$40B in total insured losses from Harvey, including $5B-$15B in National Flood Insurance Program, or NFIP, claims. P&C stocks the firm covers have declined 2.7% on average since August 23, noted Pan, who thinks the uncertainty of losses will remain a near-term overhang on the group. If the ultimate losses are contained within quarterly earnings, the stocks could rebound, added Pan. Stocks in the P&C insurance space include Allstate (ALL), Travelers (TRV), Progressive (PGR), Chubb (CB), AIG (AIG).
BBVA Banco Bilbao
$8.68

-0.01 (-0.12%)

02/15/17
JPMS
02/15/17
UPGRADE
JPMS
Overweight
Banco Bilbao upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Sofie Peterzens upgraded Banco Bilbao to Overweight with an increased price target of EUR 6.75.
02/23/17
SOCG
02/23/17
INITIATION
SOCG
Sell
Banco Bilbao initiated with a Sell at Societe Generale
03/22/17
LEHM
03/22/17
UPGRADE
LEHM
Overweight
Banco Bilbao upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Rohith Chandrarajan upgraded Banco Bilbao to Overweight with a price target of EUR 7.80.
05/04/17
UBSW
05/04/17
UPGRADE
UBSW
Neutral
Banco Bilbao upgraded to Neutral from Sell at UBS
MET MetLife
$52.72

-0.01 (-0.02%)

10/03/17
WELS
10/03/17
NO CHANGE
Target $60
WELS
Outperform
MetLife price target raised to $60 from $55 at Wells Fargo
Wells Fargo analyst Sean Dargan raised his price target for MetLife to $60 from $55 on valuation. The analyst believes the shares will continue to re-rate as its business model becomes less volatile post the spin of Brighthouse. He reiterates an Outperform rating on the stock.
10/10/17
FBRC
10/10/17
DOWNGRADE
Target $52
FBRC
Neutral
MetLife downgraded to Neutral from Buy at FBR Capital
FBR Capital analyst Randy Binner downgraded MetLife (MET) to Neutral and lowered his price target for the shares to $52 from $53 ahead of the Q3 reporting season. Binner this morning also upgraded Prudential (PRU) to Buy.
08/28/17
FBCO
08/28/17
NO CHANGE
Target $53
FBCO
Neutral
MetLife price target lowered to $53 from $64 at Credit Suisse
Credit Suisse analyst John Nadel lowered his price target for MetLife (MET) to $53 from $64 to reflect the completed separation of 80% of Brighthouse Financial (BHF). The analyst reiterates a Neutral rating on MetLife's shares.
08/10/17
WELS
08/10/17
NO CHANGE
Target $55
WELS
Outperform
MetLife added to Priority Stock List at Wells Fargo
Wells Fargo analyst Sean Dargan added MetLife to his firm's Priority Stock List saying the stock is his firm's new top pick within U.S. Life Insurers. The analyst believes MetLife will "re-rate" higher over the next year with the spin-out of Brighthouse removing earnings volatility. Dargan has an Outperform rating on the shares with a $55 price target.
C Citi
$72.11

-0.26 (-0.36%)

10/13/17
FBCO
10/13/17
NO CHANGE
Target $83
FBCO
Outperform
Citi decline on earnings due to soft credit card guidance, says Credit Suisse
Credit Suisse analyst Susan Katzke says yesterday's 3.4% slide in Citigroup stock price in spite of the earnings beat is likely due to its credit card guidance. Katzke says that even if Citi's North American card results fall 25% short of her forecast, it would result in a "manageable" 2% hit to EPS, maintaining her Outperform rating and $83 price target.
10/09/17
FBCO
10/09/17
NO CHANGE
Target $83
FBCO
Outperform
Citi price target raised to $83 from $73 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke raised her price target for Citi to $83 from $73 on valuation. The analyst reiterates an Outperform rating on the shares.
10/02/17
WELS
10/02/17
NO CHANGE
WELS
Outperform
Citi may have 'even more upside potential,' says Wells Fargo
Wells Fargo analyst Mike Mayo says Citigroup remains his top bank selection, but could have even more upside potential with restructuring. The analyst believes Citi can sell parts easier than realized, especially given only ''limited'' countries where consumer and institutional are highly integrated and an ability to divest consumer assets mostly by geography. Citi should at least remain open to more restructuring, he contends. He reiterates an Outperform rating on the shares.
09/11/17
SOCG
09/11/17
UPGRADE
SOCG
Hold
Citi upgraded to Hold from Sell at Societe Generale
CS Credit Suisse
$15.83

0.11 (0.70%)

09/26/17
SANT
09/26/17
UPGRADE
SANT
Buy
Credit Suisse upgraded to Buy from Underperform at Santander
10/06/17
RBCM
10/06/17
UPGRADE
RBCM
Outperform
Credit Suisse upgraded to Outperform from Sector Perform at RBC Capital
09/11/17
SOCG
09/11/17
UPGRADE
SOCG
Buy
Credit Suisse upgraded to Buy from Hold at Societe Generale
08/01/17
SBSH
08/01/17
NO CHANGE
SBSH
Credit Suisse added to Focus List Europe at Citi
Citi analyst Andrew Coombs added Credit Suisse to his firm's Focus List Europe saying better than expected pretax profits in 2018 will drive the shares higher.
SPGI S&P Global
$161.82

0.7 (0.43%)

05/01/17
FBCO
05/01/17
NO CHANGE
Target $155
FBCO
Outperform
S&P Global price target raised to $155 from $131 at Credit Suisse
Credit Suisse analyst Anjaneya Singh raised his price target for S&P Global to $155 from $131 after the company exceeded expectations for the quarter, driven by strength across its Ratings business segment and by strong contributions from other segments. While there may be questions on the momentum of issuance for the remainder of 2017, the analyst believes the potential risks are offset by opportunities for S&P Global PGI in its other businesses, on both top line and margins. He reiterates an Outperform rating on the shares.
07/28/17
UBSW
07/28/17
NO CHANGE
Target $173
UBSW
Buy
S&P Global price target raised to $173 from $154 at UBS
UBS analyst Alex Kramm raised his price target on S&P Global to $173 from $154 following strong Q2 results. The analyst noted its raised guidance for both organic revenue and earnings and he sees the company further unlocking revenue and margin opportunities. Kramm reiterated his Buy rating on S&P Global shares.
04/26/17
UBSW
04/26/17
NO CHANGE
Target $154
UBSW
Buy
S&P Global price target raised to $154 from $140 at UBS
UBS analyst Alex Kramm raised his price target on S&P Global to $154 from $140 following Q1 results. The analyst believes the company's raised guidance is its first after a Q1 release, noting that it cited solid organic growth and margin expansion across all segments. Kramm believes investors are not fully appreciating the value of the company's non-rating segments, which he believes should continue to deliver this year. Kramm reiterated his Outperform rating on S&P Global shares.
04/17/17
RAJA
04/17/17
UPGRADE
Target $143
RAJA
Outperform
S&P Global upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Patrick O'Shaughnessy upgraded S&P Global and established a $143 price target. The analyst views valuation as reasonable and expects S&P to generate consistent double-digit earnings growth due to steady revenue growth, margin expansion, and healthy capital returns.
BCS Barclays

05/17/17
UBSW
05/17/17
UPGRADE
UBSW
Buy
Barclays upgraded to Buy from Neutral at UBS
UBS analyst Jason Napier upgraded Barclays to Buy from Neutral citing its relative underperformance and its discount valuation relative to its Net Asset Value. He also does not believe the bank is facing a near-term capital shortfall, which has been a source of investor concern. He lowered his price target on Barclays shares to 235p from 240p.
06/01/17
GSCO
06/01/17
UPGRADE
GSCO
Buy
Barclays Africa Group upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Waleed Mohsin upgraded Barclays Africa Group (AGRPY) to Buy saying the Barclays (BSC) stake sale removes a technical overhang. The analyst views current share levels as an attractive entry point.
06/02/17
JPMS
06/02/17
UPGRADE
JPMS
Overweight
Barclays upgraded to Overweight from Neutral at JPMorgan (yesterday)
JPMorgan analyst Raul Sinha yesterday morning upgraded Barclays to Overweight with an increased price target of 240p. The Africa disposal unlocks capital creating earnings upside, the analyst told investors.
05/05/17
GSCO
05/05/17
DOWNGRADE
GSCO
Sell
Barclays downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Martin Leitgeb downgraded Barclays to Sell and lowered his price target for the shares to 180p from 250p.
CG Carlyle Group
$24.05

0.1 (0.42%)

10/10/17
10/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HSBC (HSBC) downgraded to Underperform from Neutral at Credit Suisse with analyst Sanjay Jain citing valuation. 2. Jabil Circuit (JBL) downgraded to Sell from Neutral at Goldman Sachs with analyst Mark Delaney saying street expectations, which assume Jabil's earnings grow double digits year-over-year for both of the next two years, are overly optimistic. 3. Carlyle Group (CG) downgraded to Neutral from Buy at Citi with analyst William Katz citing valuation with the shares up 60% year-to-date. 4. Eli Lilly (LLY) downgraded to Neutral from Outperform at Credit Suisse with analyst Vamil Divan saying the valuation looks full with the shares up 13% since mid-August. 5. Ralph Lauren (RL) downgraded to Sell from Hold at Miller Tabak. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/08/17
BOFA
06/08/17
UPGRADE
BOFA
Buy
Carlyle Group upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Michael Carrier upgraded Carlyle Group (CG) to Buy saying the outlook for alternative asset managers is improving following a challenging 2015 and 2016. The analyst highlights "healthy" fundraising, improving returns, and rising distributions for the space. Carrier raised his price target for Carlyle to $21 from $20 while noting that Apollo Global (APO) remains his top pick in the space.
10/10/17
SBSH
10/10/17
DOWNGRADE
Target $25.5
SBSH
Neutral
Carlyle Group downgraded to Neutral from Buy at Citi
Citi analyst William Katz downgraded Carlyle Group to Neutral citing valuation with the shares up 60% year-to-date. The analyst keeps a $25.50 price target for the shares.
05/11/17
FBCO
05/11/17
UPGRADE
Target $23
FBCO
Outperform
Carlyle Group upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Craig Siegenthaler upgraded Carlyle Group to Outperform and maintained a $23 price target. The analyst believes fee-related earnings could expand by 2-3x by 2019-20 as fundraising accelerates, accrued investments generate sizable returns, and sees significant valuation expansion as fundamentals improved.
BAC Bank of America
$25.83

0.38 (1.49%)

08/09/17
WELS
08/09/17
INITIATION
WELS
Outperform
Bank of America resumed with an Outperform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of Bank of America with an Outperform rating and $30 price target.
07/18/17
NOMU
07/18/17
NO CHANGE
Target $27
NOMU
Buy
Bank of America NII softness could weight on shares, says Nomura Instinet
Nomura Instinet analyst Steven Chubak said Bank of America reported a modest core beat but the NII miss and elevated bar for Q3 could result in modest share underperformance. The analyst remains encouraged by fee income resiliency, favorable credit trends, strong capital build, and compelling risk/reward, and reiterates his Buy rating and $27 price target.
07/11/17
BARD
07/11/17
NO CHANGE
BARD
Big bank set-up not great, would sell into extended rally, says Baird
Baird analyst David George does not see a great set-up for money-center banks heading into Q2 earnings. He said the trade looks crowded and he would be a seller into an extended rally. George said the risk/reward is less attractive following the sector's most recent rally as economic growth remains muted and the pace of NIM expansion may slow. George believes the biggest potential catalyst would be a gradual steepening of the yield curve and pick-up on loan growth.
06/09/17
RBCM
06/09/17
NO CHANGE
RBCM
House financial reform bill unlikely to advance in Senate, says RBC Capital
RBC Capital analyst Gerard Cassidy says that the financial regulation reform bill passed yesterday by the House would help the banking sector but probably won;t be passed by the Senate. Large publicly traded banks include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
TRI Thomson Reuters
$46.81

0.38 (0.82%)

06/15/17
06/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. La Quinta (LQ) upgraded to Overweight from Equal Weight at Morgan Stanley with the firm's analyst indicating a more bullish outlook for lodging demand given the stronger economy and raised La Quinta estimates, and notes shares have underperformed year-to-date. 2. Paccar (PCAR) upgraded to Buy from Neutral at Goldman Sachs with analyst Jerry Revinch saying he is positive on the company's prospects to further improve its industry-leading returns on capital. 3. Thomson Reuters (TRI) upgraded to Outperform from Neutral at Macquarie with analyst Giasone Salati saying he now believes the company is well positioned for what might be a once-in-a-decade boost in demand for services by MIFID II investment firms. 4. Beazer Homes (BZH) upgraded to Outperform from Neutral at Wedbush with analyst Jay McCanless citing what he sees as "the loosening of credit standards at Fannie Mae (FNMA)." 5. Enterprise Products (EPD) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Tom Abrams citing relative valuation and said the company should benefit from improving ethane markets over the next few years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/17
DBAB
06/19/17
UPGRADE
Target $50
DBAB
Buy
Thomson Reuters upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Ato Garrett upgraded Thomson Reuters to Buy and raised his price target for the shares to $50 from $44. Improving growth from the Financial and Risk segment makes the company well positioned for the back half of the year, Garrett tells investors in a research note.
09/06/17
TDSI
09/06/17
UPGRADE
TDSI
Buy
Thomson Reuters upgraded to Buy from Hold at TD Securities
TD Securities analyst Vince Valentini upgraded Thomson Reuters to Buy due to recent share weakness and expectations revenue growth will accelerate in the second half 2017.
10/03/17
MACQ
10/03/17
NO CHANGE
Target $58
MACQ
Outperform
Thomson Reuters price target raised to $58 from $51 at Macquarie
Macquarie analyst Giasone Salati raised Outperform rated Thomson Reuters' price target to $58 from $51 and increased estimates to reflect the "explosion" in data requirements for MiFID regulation and resulting higher margin forecasts.
BK BNY Mellon
$54.67

-0.07 (-0.13%)

05/26/17
BOFA
05/26/17
INITIATION
Target $49
BOFA
Underperform
BNY Mellon reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Michael Carrier reinstated coverage on BNY Mellon with an Underperform and a $49 price target given low revenue growth outlook.
08/09/17
WELS
08/09/17
INITIATION
Target $55
WELS
Market Perform
BNY Mellon initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo started BNY Mellon with a Market Perform rating and $55 price target.
10/13/17
GSCO
10/13/17
NO CHANGE
GSCO
McDonald's 'can outperform for several more years,' says Goldman Sachs
Goldman Sachs analyst Karen Holthouse says historical analysis indicates that McDonald's (MCD) can continue to outperform and gain market share at the expense of regional competitors. According to the analyst, after fast food companies underperform for three quarters, they go on to underperform for an average of 4.6 years. Seven of McDonald's "key competitors...are relatively early in these cycles of underperformance," the analyst wrote. However, Holthouse believes that the risk to Wendy's (WEN) and Restaurant Brands' (QSR) Burger King from McDonald's rebound "may be overstated," since Burger King and Wendy's would only have to gain 30 basis points of share from other fast food players to offset a 5% comp sales gain by McDonald's, according to the analyst. The analyst trimmed her price target on McDonald's to $172 from $174, citing a "modeling error." She cut her price target on Bojangles (BOJA) to $12.50 from $14.50 and lowered her fiscal 2018 comp sales estimates for Bojangles, Dunkin' Brands (DNKN), and Restaurant Brands, citing the latter company's ownership of Popeye's. She sees Bojangle's, Jack in the Box (JACK), and Dunkin Brands as having the most risk, in order from greatest to least, from McDonald's resurgence.
09/08/17
UBSW
09/08/17
DOWNGRADE
UBSW
Neutral
BNY Mellon downgraded to Neutral from Buy at UBS
AB AllianceBernstein
$25.00

-0.2 (-0.79%)

06/05/17
SIDC
06/05/17
INITIATION
Target $28
SIDC
Buy
AllianceBernstein initiated with a Buy at Sidoti
Sidoti initiated AllianceBernstein with a Buy and a $28 price target.
04/12/17
BOFA
04/12/17
UPGRADE
BOFA
Buy
AllianceBernstein upgraded to Buy from Underperform at BofA/Merrill
BofA/Merrill analyst Michael Carrier upgraded AllianceBernstein two notches to Buy from Underperform and raised its price target to $25 from $24 to reflect increased confidence in organic growth outlook and believes with a greater than 8% yield, shares are undervalued.
04/11/17
KBWI
04/11/17
UPGRADE
KBWI
Outperform
AllianceBernstein upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette upgraded AllianceBernstein to Outperform from Market Perform with a $26 price target, citing attractive risk/reward.
12/16/16
BOFA
12/16/16
DOWNGRADE
Target $22
BOFA
Underperform
AllianceBernstein downgraded to Underperform from Buy at BofA/Merrill
BofA/Merrill analyst Michael Carrier downgraded AllianceBernstein two notches to Underperform and lowered its price target to $22 from $25. The analyst does not expect the company to benefit from U.S. tax reform given its structure and expects a rotation out of fixed income to impact organic growth.

TODAY'S FREE FLY STORIES

02:40
10/24/17
10/24
02:40
10/24/17
02:40
General news
FX Update: The dollar majors have posted relatively narrow ranges »

FX Update: The dollar…

NVS

Novartis

$85.91

0.17 (0.20%)

, MCD

McDonald's

$163.34

-2.96 (-1.78%)

20:25
10/23/17
10/23
20:25
10/23/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

NVS

Novartis

$85.91

0.17 (0.20%)

MCD

McDonald's

$163.34

-2.96 (-1.78%)

MMM

3M

$221.55

0.23 (0.10%)

UTX

United Technologies

$120.89

-0.04 (-0.03%)

LLY

Eli Lilly

$87.18

-0.05 (-0.06%)

LMT

Lockheed Martin

$320.73

0.73 (0.23%)

CAT

Caterpillar

$131.68

0.32 (0.24%)

BIIB

Biogen

$328.55

-9.55 (-2.82%)

GM

General Motors

$45.15

-0.46 (-1.01%)

SHW

Sherwin-Williams

$386.58

-3.12 (-0.80%)

INFY

Infosys

$14.83

0.27 (1.85%)

GLW

Corning

$30.01

-0.05 (-0.17%)

PCAR

Paccar

$74.65

-0.27 (-0.36%)

SWK

Stanley Black & Decker

$158.19

-1.93 (-1.21%)

FITB

Fifth Third

$28.43

-0.17 (-0.59%)

CNC

Centene

$97.99

1.49 (1.54%)

WAT

Waters

$187.55

-0.59 (-0.31%)

IPG

Interpublic Group

$20.63

-0.25 (-1.20%)

WAB

Wabtec

$76.39

-0.48 (-0.62%)

HUBB

Hubbell

$121.32

-1.75 (-1.42%)

JBLU

JetBlue

$19.88

-0.47 (-2.31%)

PII

Polaris Industries

$106.92

0.46 (0.43%)

GPK

Graphic Packaging

$14.27

-0.01 (-0.07%)

R

Ryder

$82.94

-0.71 (-0.85%)

CVLT

Commvault

$57.90

-0.65 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 13

    Nov

  • 30

    Nov

  • 04

    Dec

  • 07

    Dec

  • 17

    May

PINC

Premier

$34.21

0.04 (0.12%)

20:14
10/23/17
10/23
20:14
10/23/17
20:14
Downgrade
Premier rating change at KeyBanc »

Premier downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBTX

Veritex

$26.94

-0.17 (-0.63%)

19:29
10/23/17
10/23
19:29
10/23/17
19:29
Earnings
Veritex reports Q3 core EPS 28c, consensus 30c »

For the three months…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

OIBR

Oi S.A.

19:08
10/23/17
10/23
19:08
10/23/17
19:08
Hot Stocks
Oi: Court postpones general meeting of creditors »

Oi announced that, at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAS

Hasbro

$89.75

-8.44 (-8.60%)

18:24
10/23/17
10/23
18:24
10/23/17
18:24
Hot Stocks
Hasbro CEO: Had a very strong quarter »

Expects to make a revised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

LGF.A

Lionsgate

$29.59

-0.5 (-1.66%)

, LGF.B

Lionsgate

$28.44

-0.6 (-2.07%)

18:07
10/23/17
10/23
18:07
10/23/17
18:07
Hot Stocks
Lionsgate names Rohit Jain to head new office in Mumbai, India »

Lionsgate (LGF.A, LGF.B)…

LGF.A

Lionsgate

$29.59

-0.5 (-1.66%)

LGF.B

Lionsgate

$28.44

-0.6 (-2.07%)

DISH

Dish

$48.98

-0.32 (-0.65%)

VDTH

Videocon d2h

$8.00

-0.22 (-2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 09

    Nov

ALE

Allete

$78.62

-0.31 (-0.39%)

18:06
10/23/17
10/23
18:06
10/23/17
18:06
Hot Stocks
Wisconsin jury delivers verdict in favor of U.S. Water in Novozymes suit »

U.S. Water, an Allete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 05

    Nov

SYT

Syngenta

$92.12

0.05 (0.05%)

, ADAM

A.D.A.M.

18:04
10/23/17
10/23
18:04
10/23/17
18:04
Hot Stocks
Syngenta and Adama to sell portfolio of crop products to Nufarm for $490M »

Syngenta (SYT) announced…

SYT

Syngenta

$92.12

0.05 (0.05%)

ADAM

A.D.A.M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$98.70

-0.7 (-0.70%)

17:54
10/23/17
10/23
17:54
10/23/17
17:54
Periodicals
Disney sees new 'Thor' movie outpacing earlier ones, Bloomberg says »

Disney sees "Thor:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

VIVO

Meridian Bioscience

$15.20

-0.6 (-3.80%)

17:31
10/23/17
10/23
17:31
10/23/17
17:31
Hot Stocks
Meridian Bioscience comments on FDA Warning Letter issued to subsidiary »

Meridian Bioscience…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRN

Blue Apron

$5.15

0.07 (1.38%)

17:30
10/23/17
10/23
17:30
10/23/17
17:30
Hot Stocks
Blue Apron names Lainie Cooney chief HR officer »

Blue Apron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

WSFS

WSFS Financial

$50.25

-0.5 (-0.99%)

17:29
10/23/17
10/23
17:29
10/23/17
17:29
Hot Stocks
WSFS Financial raises quarterly dividend 29% to 9c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 15

    Nov

CONN

Conn's

$26.85

-0.75 (-2.72%)

17:28
10/23/17
10/23
17:28
10/23/17
17:28
Hot Stocks
Conn's sees Q3 SSS down 9% to down 5%, provision for bad debts at $56M-$61M »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSFS

WSFS Financial

$50.25

-0.5 (-0.99%)

17:27
10/23/17
10/23
17:27
10/23/17
17:27
Earnings
WSFS Financial reports Q3 EPS 64c, consensus 65c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 15

    Nov

VBTX

Veritex

$26.94

-0.17 (-0.63%)

17:27
10/23/17
10/23
17:27
10/23/17
17:27
Hot Stocks
Veritex names Michael Bryan chief information officer »

Veritex Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

TNDM

TNDM

17:25
10/23/17
10/23
17:25
10/23/17
17:25
Hot Stocks
Breaking Hot Stocks news story on TNDM »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CLB

Core Laboratories

$87.75

-1.74 (-1.94%)

17:21
10/23/17
10/23
17:21
10/23/17
17:21
Hot Stocks
Core Laboratories sees Q4 free cash flow exceeding net income »

Fourth quarter 2017 FCF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CLB

Core Laboratories

$87.75

-1.74 (-1.94%)

17:20
10/23/17
10/23
17:20
10/23/17
17:20
Earnings
Core Laboratories sees Q4 revenue approximately 58c, consensus 58c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CLB

Core Laboratories

$87.75

-1.74 (-1.94%)

17:18
10/23/17
10/23
17:18
10/23/17
17:18
Earnings
Core Laboratories reports Q3 GAAP EPS 48c, consensus 44c »

Reports Q3 revenue $166M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

LKQ

LKQ Corp.

$37.06

-0.28 (-0.75%)

, DOV

Dover

$95.54

0.59 (0.62%)

17:17
10/23/17
10/23
17:17
10/23/17
17:17
Hot Stocks
LKQ Corp to acquire aftermarket business of Dover subsidiary Warn Industries »

LKQ Corporation (LKQ)…

LKQ

LKQ Corp.

$37.06

-0.28 (-0.75%)

DOV

Dover

$95.54

0.59 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

KNL

Knoll

$20.00

-0.02 (-0.10%)

, HMST

HomeStreet

$28.60

-0.25 (-0.87%)

17:17
10/23/17
10/23
17:17
10/23/17
17:17
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Knoll…

KNL

Knoll

$20.00

-0.02 (-0.10%)

HMST

HomeStreet

$28.60

-0.25 (-0.87%)

CR

Crane

$83.61

-0.5 (-0.59%)

IPXL

Impax

$20.35

-0.9 (-4.24%)

ICPT

Intercept

$65.60

-1.25 (-1.87%)

SWK

Stanley Black & Decker

$158.19

-1.93 (-1.21%)

NKE

Nike

$53.66

0.6 (1.13%)

HNI

HNI Corporation

$42.29

-0.57 (-1.33%)

WHR

Whirlpool

$182.50

0.04 (0.02%)

ZION

Zions Bancorp

$46.39

-0.37 (-0.79%)

JBT

John Bean Technologies

$104.05

0.1 (0.10%)

IMDZ

Immune Design

CRBP

Corbus Pharmaceuticals

$7.40

-0.375 (-4.82%)

QURE

uniQure

$18.52

-0.75 (-3.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

HBI

Hanesbrands

$22.86

-0.63 (-2.68%)

17:17
10/23/17
10/23
17:17
10/23/17
17:17
Initiation
Hanesbrands initiated at Deutsche Bank »

Hanesbrands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

PVH

PVH Corp.

$129.68

1.37 (1.07%)

17:15
10/23/17
10/23
17:15
10/23/17
17:15
Initiation
PVH Corp. initiated at Deutsche Bank »

PVH Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$19.55

0.1 (0.51%)

17:15
10/23/17
10/23
17:15
10/23/17
17:15
Hot Stocks
Breaking Hot Stocks news story on New York Times »

Darsana Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.